Computational repurposing of oncology drugs through off‐target drug binding interactions from pharmacological databases

Documenti analoghi

• PBPK‐led assessment of antimalarial drugs as candidates for Covid‐19: Simulating concentrations at the site of action to inform repurposing strategies
  di: Nada Abla, et al.
  Pubblicazione: (2024)
• Evaluation of potential drug–drug interactions with medical cannabis
  di: Jessie Jia Yi Ho, et al.
  Pubblicazione: (2024)
• Computational drug discovery pipelines identify NAMPT as a therapeutic target in neuroendocrine prostate cancer
  di: Weijie Zhang, et al.
  Pubblicazione: (2024)
• Proposing a framework to quantify the potential impact of pharmacokinetic drug–drug interactions caused by a new drug candidate by using real world data about the target patient population
  di: Simon Dagenais, et al.
  Pubblicazione: (2024)
• Critical evaluation of real‐world evidence of repurposable medicines in the Alzheimer's disease drug development pipeline using a target trial emulation
  di: Reina Tonegawa‐Kuji, et al.
  Pubblicazione: (2025)